Literature DB >> 12165658

S-100 protein+ dendritic cells and CD34+ dendritic interstitial cells in thyroid lesions.

Anna Batistatou1, Vassiliki Zolota, Chrisoula D Scopa.   

Abstract

Dendritic cells (DCs) are antigen-presenting cells and mature from precursor CD34+ stromal cells (dendritic interstitial cells [DICs]) or monocytes. The aim of the present study was to gain insight into the local immune response to various thyroid lesions. We investigated, immunohistochemically, the presence of S-100+ DCs and CD34+ DICs in 13 papillary carcinomas, 10 follicular carcinomas, 7 follicular adenomas, 1 Hurthle cell carcinoma, 1 Hurthle cell adenoma, 2 medullary carcinomas, 6 undifferentiated carcinomas, and 3 nodular goiters. Dense infiltrates of S-100+ DCs were noted in the majority of papillary carcinomas (mean: 66.4), while moderate infiltrates were observed in follicular adenomas (mean: 23.3), follicular carcinomas (mean: 23.5), and undifferentiated carcinomas (mean: 31.6). The remaining lesions showed slight infiltrates of scattered DCs. DICs were noted exclusively in neoplastic lesions, specifically at the periphery and within the tumor capsule. The increased number of DCs in papillary carcinomas is possibly correlated with their good prognosis. The specific distribution of DICs suggests a possible contribution to growth regulation of thyroid neoplasms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165658     DOI: 10.1385/ep:13:2:111

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  16 in total

1.  Dendritic cells: at the clinical crossroads.

Authors:  J J Mulé
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

2.  Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.

Authors:  S Schröder; W Schwarz; W Rehpenning; T Löning; W Böcker
Journal:  Am J Clin Pathol       Date:  1988-03       Impact factor: 2.493

3.  The specific distribution of dendritic interstitial cells at the tumor border of major salivary gland pleomorphic adenomas.

Authors:  H Nakayama; K Naruse; E Miyazaki; M Hiroi; H Kiyoku; N Kuroda; H Enzan
Journal:  Mod Pathol       Date:  1999-05       Impact factor: 7.842

4.  Cylindroma expresses immunohistochemical markers linking it to eccrine coil.

Authors:  N S Penneys; M Kaiser
Journal:  J Cutan Pathol       Date:  1993-02       Impact factor: 1.587

5.  T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis.

Authors:  T Furukawa; S Watanabe; T Kodama; Y Sato; Y Shimosato; K Suemasu
Journal:  Cancer       Date:  1985-12-01       Impact factor: 6.860

6.  Histiocytes in nasopharyngeal carcinoma in relation to prognosis.

Authors:  H Nomori; S Watanabe; T Nakajima; Y Shimosato; T Kameya
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

7.  Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms.

Authors:  T T Kirchmann; V G Prieto; B R Smoller
Journal:  J Cutan Pathol       Date:  1995-10       Impact factor: 1.587

8.  S-100 protein-positive dendritic cells in follicular lesions of the thyroid.

Authors:  M Hirokawa; M Shimizu; T Manabe; H Sonoo; T Harada
Journal:  APMIS       Date:  1998-07       Impact factor: 3.205

9.  CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.

Authors:  T T Kirchmann; V G Prieto; B R Smoller
Journal:  Arch Dermatol       Date:  1994-05

10.  In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

Authors:  D Bell; P Chomarat; D Broyles; G Netto; G M Harb; S Lebecque; J Valladeau; J Davoust; K A Palucka; J Banchereau
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

View more
  7 in total

1.  Differential expression of dysadherin in papillary thyroid carcinoma and microcarcinoma: correlation with E-cadherin.

Authors:  Anna Batistatou; Konstantinos Charalabopoulos; Yukihiro Nakanishi; Constantine Vagianos; Setsuo Hirohashi; Niki J Agnantis; Chrissoula D Scopa
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

2.  Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.

Authors:  Hang Yu; Xiaomei Huang; Xiaosun Liu; Hailong Jin; Ge'er Zhang; Qing Zhang; Jiren Yu
Journal:  Endocrine       Date:  2012-12-22       Impact factor: 3.633

3.  Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer.

Authors:  Jill J Bastman; Hilary S Serracino; Yuwen Zhu; Michelle R Koenig; Valerica Mateescu; Sharon B Sams; Kurtis D Davies; Christopher D Raeburn; Robert C McIntyre; Bryan R Haugen; Jena D French
Journal:  J Clin Endocrinol Metab       Date:  2016-04-05       Impact factor: 5.958

4.  Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.

Authors:  Han Shuwen; Yang Xi; Da Miao; Xu Jiamin; Zhuang Jing; Gao Weili
Journal:  Dis Markers       Date:  2020-06-16       Impact factor: 3.434

5.  Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma.

Authors:  Jinyuan Shi; Pu Wu; Lei Sheng; Wei Sun; Hao Zhang
Journal:  Cancer Cell Int       Date:  2021-12-14       Impact factor: 5.722

6.  Morphologic evidence of telocytes in human thyroid stromal tissue.

Authors:  Irene Rosa; Lidia Ibba-Manneschi; Daniele Guasti; Giuliano Perigli; Maria-Simonetta Faussone-Pellegrini; Mirko Manetti
Journal:  J Cell Mol Med       Date:  2022-03-20       Impact factor: 5.310

Review 7.  Novel targeted therapies and immunotherapy for advanced thyroid cancers.

Authors:  George E Naoum; Michael Morkos; Brian Kim; Waleed Arafat
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.